Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Effect of Gum Arabic supplementation on butyrate, uremic retention molecules and inflammation in chronic kidney disease patients King Fahad Specialist Hospital - Dammam Ongoing Gum Arabic / E-114 2 2 King Fahad Specialist Hospital (Dammam)
Effects of Add on Pegylated Interferon therapy in patients of Chronic hepatitis B in maintained response with ongoing nucleos(t)ide analogues ; A multicenter, prospective, randomized open label trial. KAIMRC Ongoing PEGINTERFERON ALFA-2A/ RIBAVIRIN/ R0209963 3 RC14-055-R King Abdulaziz Medical City NG (Riyadh)
Efficacy and Safety of Intensive Insulin Therapy With Insulin Glulisine in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs Sanofi Ongoing Lantus® / Apidra® 4 LANTU_R_05048 National Diabetes Centre (Riyadh)
An observational study to monitor 2- Combination regimen's patterns of oral hypoglycaemic agents in Type 2 diabetic patients in daily clinical practice in Saudi Arabia Sanofi Ongoing 2-combination hypoglycaemics 4 DIREG_L_05386 Dr. Erfan & Bagedo General Hospital (Jeddah)
Registry of treatment patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) with progression during or after DOCETAXEL-based regimen Sanofi Ongoing N/A 4 DRIEG_C_05756 King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
An observational Study to evaluate the behaviour of physicians focusing on the preference patterns (reasons to prescribe) of ARB/HCTZ combinations containing high dose (25mg) diuretic for treatment of hypertension in Saudi Arabia Sanofi Ongoing N/A 4 IRBEH_L_05674 King Khalid University Hospital (Riyadh)
Effect of ACS Patients' Education on Adherence to Dual Anti-platelet Therapy (unstable angina + non ST elevation MI + ST elevation MI) Sanofi Ongoing N/A 4 DIREG_L_05229 Dr. Soliman Fakeeh Hospital (Jeddah)
Phase IV, Multicenter, International, Non-comparative, Open Label Study of Efficacy and Safety of Basal Bolus Therapy (Insulin Glargine + Insulin Glulisine) in Patients With T1 Diabetes Previously Uncontrolled on Any Insulin Regimen. Sanofi Ongoing Lantus® + Apidra® 4 LANTU_R_05033 King Khalid University Hospital (Riyadh)
Study of clinical and non clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice Sanofi Ongoing Lantus®/Apidra® 4 LANTUR06314 Dr. Erfan & Bagedo General Hospital (Jeddah)
Registry on the use of Lactic acid (Lactacyd) in minor gynecologyical conditions among Middle Eastren women Sanofi Ongoing LACTOSERUM LACTIC ACID 4 LACACL06308 Dr. Erfan & Bagedo General Hospital (Jeddah)
View 641 - 650 From 774